MedPath

Synalar

SYNALAR (fluocinolone acetonide) Ointment, 0.025%

Approved
Approval ID

d2d155cf-a635-4ab7-87de-34e90b9a74cd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 29, 2023

Manufacturers
FDA

Medimetriks Pharmaceuticals, Inc.

DUNS: 019903816

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

fluocinolone acetonide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43538-910
Application NumberNDA013960
Product Classification
M
Marketing Category
C73594
G
Generic Name
fluocinolone acetonide
Product Specifications
Route of AdministrationTOPICAL
Effective DateNovember 29, 2023
FDA Product Classification

INGREDIENTS (2)

fluocinolone acetonideActive
Quantity: 0.25 mg in 1 g
Code: 0CD5FD6S2M
Classification: ACTIB
petrolatumInactive
Code: 4T6H12BN9U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Synalar - FDA Drug Approval Details